feed,title,long_url,short_url
Investors,Neurocrine Bio Tops Fourth-Quarter Views As Profit Skyrockets,https://www.investors.com/news/technology/nbix-stock-neurocrine-earnings-q4-2022/,https://da.gd/UL8a4Z
